
BASF acquires global leader in omega-3 fatty acids for the pharmaceutical industry
Ludwigshafen, Germany - May 9, 2012 today announced the acquisition of Equateq Ltd., a global leader in the manufacture of highly concentrated omega-3 fatty acids.



Higher concentrates at greater efficiency are achievable by converting TG oils to Free Fatty Acid or Ethyl Ester form followed by crystallization or distillation. We typically produce this specification as an interim feedstock for making our Maxomega range. Both EE and FFA forms may then be re-constituted under mild conditions to a Triglyceride form.
Our Intermediates Range: highly concentrated fatty acids.